1. HBW Insight
  2. >>Wellness

GSK Plans Further Divestments As Pfizer Brands Drive Up Q3 Sales

 
• By Tom Gallen

GSK is plotting further divestments into next year as it looks to focus its portfolio on key categories and raise funds to cover the costs of integrating Pfizer's Consumer Healthcare business. In the third quarter, GSK's sales advanced double-digits thanks to the inclusion of Pfizer megabrands like Advil and Centrum.

Ladder made of coins with colorful pills on top suggesting the growing prices of medicine or drugs

GlaxoSmithKline PLC portfolio rationalization efforts, which has seen it shed mainly skin-care and nutrition assets over the past 12 months, will continue into 2020 as the firm looks to generate the funds needed to integrate Pfizer Inc.’s Consumer Healthcare business.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business